Phase III study of adjuvant therapy with encorafenib plus binimetinib compared to placebo in completely resected BRAFV600-mutant stage IIB/C melanoma: study design of the COLUMBUS-AD
Hauschild, A. Van Akkooi, A. C. J. Long, G. V. Mandala, M. Kicinski, M. Govaerts, A. S. Klauck, I. Ouali, M. Eggermont, A. M. M.
Hauschild, A.
Van Akkooi, A. C. J.
Long, G. V.
Mandala, M.
Kicinski, M.
Govaerts, A. S.
Klauck, I.
Ouali, M.
Eggermont, A. M. M.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Hauschild A, Van Akkooi ACJ, Long GV, Mandala M, Kicinski M, Govaerts AS, et al. Phase III study of adjuvant therapy with encorafenib plus binimetinib compared to placebo in completely resected BRAFV600-mutant stage IIB/C melanoma: study design of the COLUMBUS-AD. Journal Der Deutschen Dermatologischen Gesellschaft. 2022 Sep;20:96-. PubMed PMID: WOS:000851869200160.